Cargando…
Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer
The majority of small cell lung cancer (SCLC) patients demonstrate initial chemo-sensitivity, whereas a distinct subgroup of SCLC patients, termed chemo-refractory, do not respond to treatment. There is little understanding of how to distinguish these patients prior to disease treatment. Here we use...
Autores principales: | McColl, Karen, Wildey, Gary, Sakre, Nneha, Lipka, Mary Beth, Behtaj, Mohadese, Kresak, Adam, Chen, Yanwen, Yang, Michael, Velcheti, Vamsidhar, Fu, Pingfu, Dowlati, Afshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650296/ https://www.ncbi.nlm.nih.gov/pubmed/29088741 http://dx.doi.org/10.18632/oncotarget.20572 |
Ejemplares similares
-
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
por: Sakre, Nneha, et al.
Publicado: (2016) -
Post‐transcriptional regulation of PIAS3 expression by miR‐18a in malignant mesothelioma
por: He, Tian, et al.
Publicado: (2018) -
PIAS3 expression in squamous cell lung cancer is low and predicts overall survival
por: Abbas, Rime, et al.
Publicado: (2015) -
Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer
por: He, Tian, et al.
Publicado: (2020) -
Overexpression of INSM1, NOTCH1, NEUROD1, and YAP1 genes is associated with adverse clinical outcome in pediatric neuroblastoma
por: Metovic, Jasna, et al.
Publicado: (2022)